𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differential expression of c-myc and the transferrin receptor in G1 synchronized M1 myeloid leukemia cells

✍ Scribed by Leonard M. Neckers; Hiroyuki Tsuda; Ervin Weiss; Dov H. Pluznik


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
726 KB
Volume
135
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


We have studied the transcriptional activity, steady-state mRNA levels, and steady-state protein levels of the c-myc and transferrin receptor (TfR) genes in murine M1 myeloid leukemia cells arrested in G1 phase of the cell cycle by different methods. When cells are growth-arrested by density inhibition, a technique that places the majority of cells in early G I , c-myc protein, as detected by Western analysis, is expressed at 80% of the level seen in proliferating cells. Steady-state mRNA levels and, to a lesser extent, transcriptional activity of the c-myc gene, parallel the protein findings. Under these conditions, TfR gene expression is much lower than in normally cycling cells. We have previously demonstrated that density-inhibited M1 cells, released from density inhibition and treated with the DNA polymerase alpha inhibitor aphidicolin, remain in G1, but at a point temporally closer to S phase. Cells treated in this manner demonstrate reduced transcriptional activity and expression of the c-myc gene, but TfR gene expression approximates the level found in proliferating cells. These data suggest that neither c-myc nor TfR gene expression is constant throughout the G1 phase of the cell cycle in M I cells. c-myc gene expression is highest in early G1 and falls to low levels by late G I , while the reverse is true for TfR gene expression.


πŸ“œ SIMILAR VOLUMES


Endothelin-1 enhances the expression of
✍ June G. Lee; Rong Zheng; Jennifer M. McCafferty-Cepero; Kerry L. Burnstein; Davi πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 255 KB πŸ‘ 1 views

## Abstract Increasing evidence suggests that androgen independent prostate cancer (PC) maintains a functional androgen receptor (AR) pathway despite the low levels of circulating androgen following androgen withdrawal, the molecular mechanisms of which are not well defined yet. To address this que

Polyamine depletion up-regulates c-Myc e
✍ Lennart FrostesjΓΆ; Olle Heby πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 113 KB πŸ‘ 2 views

The ornithine decarboxylase (ODC) gene is a transcriptional target of c-Myc. Exponentially growing cells usually exhibit high c-Myc levels and high ODC levels, whereas stationary phase cells and terminally differentiated cells have low levels of both proteins. Therefore, we were surprised to find th

G protein-coupled receptor agonist-stimu
✍ Laila S. Nilssen; John ØdegΓ₯rd; G. Hege Thoresen; Anders Molven; Dagny Sandnes; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 326 KB

## Abstract Several agonists acting on G protein‐coupled receptors (GPCR) enhance the mitogenic effect of epidermal growth factor (EGF) in rat hepatocytes, through mechanisms that have only partially been clarified. Results in various cells have led to the idea that a major mechanism for GPCR‐media

Differential expression of adenosine A2A
✍ Robin Munro; Rose Ressner; Maureen Stone; George Gessner; Michael F. Jarvis; Ala πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 2 views

The ability of adenosine to function as an inhibitory modulator of inflammatory processes has been well documented. While the activation of adenosine A 2 receptors has been implicated in the anti-inflammatory actions of adenosine, the specific mechanisms by which adenosine modulates the function of